Invesco Dynamic Biotechnology & Genome ETF (PBE) Position Raised by YHB Investment Advisors Inc.

YHB Investment Advisors Inc. lifted its stake in shares of Invesco Dynamic Biotechnology & Genome ETF (NYSEARCA:PBE) by 19.0% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 25,395 shares of the company’s stock after purchasing an additional 4,050 shares during the quarter. YHB Investment Advisors Inc. owned about 0.48% of Invesco Dynamic Biotechnology & Genome ETF worth $1,195,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently modified their holdings of the company. First Capital Advisors Group LLC. bought a new stake in shares of Invesco Dynamic Biotechnology & Genome ETF during the third quarter valued at about $207,000. CWM LLC raised its stake in shares of Invesco Dynamic Biotechnology & Genome ETF by 663.5% during the third quarter. CWM LLC now owns 3,199 shares of the company’s stock valued at $190,000 after purchasing an additional 2,780 shares in the last quarter. MML Investors Services LLC raised its stake in shares of Invesco Dynamic Biotechnology & Genome ETF by 15.1% during the third quarter. MML Investors Services LLC now owns 7,293 shares of the company’s stock valued at $434,000 after purchasing an additional 955 shares in the last quarter. Arlington Capital Management Inc. bought a new stake in shares of Invesco Dynamic Biotechnology & Genome ETF during the third quarter valued at about $32,680,000. Finally, SG Americas Securities LLC bought a new stake in shares of Invesco Dynamic Biotechnology & Genome ETF during the third quarter valued at about $452,000.

Shares of NYSEARCA PBE opened at $52.06 on Friday. Invesco Dynamic Biotechnology & Genome ETF has a fifty-two week low of $43.17 and a fifty-two week high of $60.49.

ILLEGAL ACTIVITY WARNING: This news story was first posted by WKRB News and is the property of of WKRB News. If you are accessing this news story on another site, it was copied illegally and reposted in violation of United States and international trademark & copyright laws. The legal version of this news story can be read at https://www.wkrb13.com/2019/01/12/invesco-dynamic-biotechnology-genome-etf-pbe-position-raised-by-yhb-investment-advisors-inc.html.

Invesco Dynamic Biotechnology & Genome ETF Company Profile

PowerShares Dynamic Biotechnology & Genome Portfolio (the Fund) is based on the Dynamic Biotechnology & Genome Intellidex Index (the Index). The Fund seeks investment results that correspond generally to the price and yield of the Index. The Index consists of stocks of 30 the United States biotechnology and genome companies.

Read More: Asset Allocation Models, Which is Right For You?

Want to see what other hedge funds are holding PBE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Invesco Dynamic Biotechnology & Genome ETF (NYSEARCA:PBE).

Institutional Ownership by Quarter for Invesco Dynamic Biotechnology & Genome ETF (NYSEARCA:PBE)

Receive News & Ratings for Invesco Dynamic Biotechnology & Genome ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invesco Dynamic Biotechnology & Genome ETF and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply